[go: up one dir, main page]

FI20011542A0 - Urosognaasigeenin monistuman käyttö - Google Patents

Urosognaasigeenin monistuman käyttö

Info

Publication number
FI20011542A0
FI20011542A0 FI20011542A FI20011542A FI20011542A0 FI 20011542 A0 FI20011542 A0 FI 20011542A0 FI 20011542 A FI20011542 A FI 20011542A FI 20011542 A FI20011542 A FI 20011542A FI 20011542 A0 FI20011542 A0 FI 20011542A0
Authority
FI
Finland
Prior art keywords
carcinomas
amplification
urogenase
gene
relates
Prior art date
Application number
FI20011542A
Other languages
English (en)
Swedish (sv)
Other versions
FI20011542A7 (fi
FI20011542L (fi
Inventor
Myoeh Ilm
Original Assignee
Fit Biotech Oyj Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fit Biotech Oyj Plc filed Critical Fit Biotech Oyj Plc
Priority to FI20011542A priority Critical patent/FI20011542L/fi
Publication of FI20011542A0 publication Critical patent/FI20011542A0/fi
Priority to PCT/FI2002/000636 priority patent/WO2003006690A1/en
Publication of FI20011542A7 publication Critical patent/FI20011542A7/fi
Publication of FI20011542L publication Critical patent/FI20011542L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI20011542A 2001-07-13 2001-07-13 Urosognaasigeenin monistuman käyttö FI20011542L (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20011542A FI20011542L (fi) 2001-07-13 2001-07-13 Urosognaasigeenin monistuman käyttö
PCT/FI2002/000636 WO2003006690A1 (en) 2001-07-13 2002-07-15 Use of urokinase gene amplification as a marker

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20011542A FI20011542L (fi) 2001-07-13 2001-07-13 Urosognaasigeenin monistuman käyttö

Publications (3)

Publication Number Publication Date
FI20011542A0 true FI20011542A0 (fi) 2001-07-13
FI20011542A7 FI20011542A7 (fi) 2003-01-14
FI20011542L FI20011542L (fi) 2003-01-14

Family

ID=8561659

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20011542A FI20011542L (fi) 2001-07-13 2001-07-13 Urosognaasigeenin monistuman käyttö

Country Status (2)

Country Link
FI (1) FI20011542L (fi)
WO (1) WO2003006690A1 (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2886946B1 (fr) * 2005-06-09 2007-08-10 Biomerieux Sa Procede pour le diagnoctic/pronostic du cancer du sein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422090A (en) * 1984-08-13 1995-06-06 Biotechnology Australia, Pty., Ltd. Human PAI-2
AU733222B2 (en) * 1997-11-25 2001-05-10 Genentech Inc. Fibroblast growth factor-19

Also Published As

Publication number Publication date
WO2003006690A1 (en) 2003-01-23
FI20011542A7 (fi) 2003-01-14
FI20011542L (fi) 2003-01-14

Similar Documents

Publication Publication Date Title
DK3059322T3 (da) Genekspressionsmarkører for brystcancerprognose
IL182423A0 (en) Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer
MXPA03003281A (es) Deteccion enzimatica no invasiva de estados asociados con la remodelacion de tejidos.
WO2006012646A3 (en) Amacr cancer markers
WO2001070979A3 (en) Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer
ATE538215T1 (de) Expressionsprofil von prostatakarzinom
EP1893196A4 (en) DIARYLHYDANTOIN CONNECTIONS
DE69940436D1 (de) Prostata stammzellantigen (psca) und dessen verwendungen
DE60226271D1 (de) Verfahren zum nachweis von prostatakrebs
AU2002337657A1 (en) Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
WO2003000012A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
UA116188C2 (uk) Інгібітори фосфатидилінозит-3-кінази і способи їх застосування
AU2001229340A1 (en) Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
DE69942827D1 (de) Verwendung der epothilons zur behandlung der krebs
WO2001042467A3 (en) Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
EP2130926A3 (en) Phage microarray profiling of the humoral response to disease
WO2005053604A3 (en) Antibodies specific for cancer associated antigen sm5-1 and uses thereof
EP1377596A4 (en) USE OF THE TTK FOR DIAGNOSTIC PURPOSES AND AS A THERAPEUTIC TARGET OF CANCER
HUP0303649A2 (hu) Mátrix-metalloproteináz-inhibitorok liposzómás célzása
WO2004031402A3 (en) Methylation profile of cancer
WO2003044161A3 (en) Gene amplification and overexpression in cancer
FR2875601B1 (fr) Vimentine phosphorylee comme marqueur de l'agressivite et/ou l'invasivite des tumeurs
EP1451552A4 (en) FOR DETECTING DISORDERS OF BREAST SUITABLE REAGENTS AND METHODS
TW200517122A (en) Antibodies specific for cancer associated antigen SM5-1 and uses thereof
FI20011542A0 (fi) Urosognaasigeenin monistuman käyttö